GlassScriptPhysician profile
James Paul Carleo
NPI 1750384228
$1,606.14
in general payments reported to CMS, 2019-2025
21 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $80.92 · 2021: $106 · 2022: $624 · 2023: $204 · 2024: $292 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $550.24 | 2019-2022 | |
| Shield Therapeutics INC | $260.82 | 2024-2025 | |
| Exeltis, USA INC. | $250.93 | 2021-2025 | Slynd |
| Astellas Pharma US INC | $103.15 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $87.86 | 2022-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
| Abbott Laboratories | $47.15 | 2022 | |
| Millicent US INC | $46.56 | 2025 | Femlyv |
| Scynexis, INC. | $40.18 | 2022 | |
| Minerva Surgical, INC | $36.31 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.53 | 2022 | |
| Vertical Pharmaceuticals, LLC | $19.36 | 2020 | |
| Sumitomo Pharma America, INC. | $18.51 | 2023 | Myfembree |
| Organon LLC | $17.97 | 2025 | Nexplanon |
| Coopersurgical, INC. | $16.20 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.08 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.32 | 2020 | |
| Agile Therapeutics, INC. | $15.13 | 2023 | Twirla |
| Boston Scientific Corporation | $14.88 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $11.50 | 2020 | |
| Evofem Biosciences, INC. | $11.12 | 2021 | |
| Mayne Pharma Commercial LLC | $4.34 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Carleo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.